Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

South Korea To Implement cGMPs On OTC Drugs To Prepare For U.S. Free Trade Agreement

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's Health, Welfare and Family Affairs Ministry will implement current good manufacturing practices regulations on all over-the-counter drugs sold at regular drug stores without doctors' prescriptions beginning in 2009

You may also be interested in...



South Korea's Pharmaceutical Output Stays Healthy

SEOUL - The outlook for Korea's pharmaceutical market remains strong with pharmaceutical production rising 9.25 percent in 2008 to KRW13.76 trillion ($12.47 billion) from 2007, Korea FDA reported

South Korea's Pharmaceutical Output Stays Healthy

SEOUL - The outlook for Korea's pharmaceutical market remains strong with pharmaceutical production rising 9.25 percent in 2008 to KRW13.76 trillion ($12.47 billion) from 2007, Korea FDA reported

KFDA To Ban 1000-plus Generic Drugs In New Blow To Korea's Domestic Pharmaceutical Companies, Potential Boost For Innovative Medicines

SEOUL - As regulators tighten checks for safety and effectiveness on South Korea's generic drugs, they have marked 1,226 products, or 58.5 percent of the 2,095 drugs examined, for elimination from the market

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel